Insights

Strategic Acquisition Boston Scientific’s acquisition of Intera Oncology indicates a scaling opportunity for integrated product portfolios and cross-sell of hepatic infusion tech, potentially easing access to larger OEM channels and distribution networks.

Targeted Market The core focus on metastatic colorectal cancer and cholangiocarcinoma presents a white-space for premium, implantable hepatic delivery solutions, suggesting a need for expanded payer engagement and case-based selling to oncology centers.

Clinical Risk Past recall and FDA flow-rate issues with the Intera 3000 highlight a sales strategy that should emphasize safety, reliability, and post-market support to win trust with hospital procurement and clinical champions.

Tech & Platform Current tech stack and Azure/cloud capabilities open opportunities for software-enabled monitoring, remote diagnostics, and data-driven outcomes reporting to differentiate from competitors.

Growth Signals Small-to-mid size employee base and notable revenue range indicate a nimble organization with potential for rapid expansion post-acquisition; target partnerships with early adopters in major cancer centers and regional networks.

Similar companies to Intera Oncology Inc. (now a part of Boston Scientific)

Intera Oncology Inc. (now a part of Boston Scientific) Tech Stack

Intera Oncology Inc. (now a part of Boston Scientific) uses 8 technology products and services including Trident AB, OneTrust, Element UI, and more. Explore Intera Oncology Inc. (now a part of Boston Scientific)'s tech stack below.

  • Trident AB
    A/B Testing
  • OneTrust
    Cookie Compliance
  • Element UI
    Javascript Frameworks
  • Windows Server
    Operating Systems
  • reCAPTCHA
    Security
  • Google Tag Manager
    Tag Management
  • Tailwind CSS
    UI Frameworks
  • Cloudflare Stream
    Video Players

Intera Oncology Inc. (now a part of Boston Scientific)'s Email Address Formats

Intera Oncology Inc. (now a part of Boston Scientific) uses at least 1 format(s):
Intera Oncology Inc. (now a part of Boston Scientific) Email FormatsExamplePercentage
FLast@interaoncology.comJDoe@interaoncology.com
96%
LastFir@interaoncology.comDoeJoh@interaoncology.com
2%
Last@interaoncology.comDoe@interaoncology.com
2%

Frequently Asked Questions

What is Intera Oncology Inc. (now a part of Boston Scientific)'s official website and social media links?

Minus sign iconPlus sign icon
Intera Oncology Inc. (now a part of Boston Scientific)'s official website is interaoncology.com and has social profiles on LinkedInCrunchbase.

What is Intera Oncology Inc. (now a part of Boston Scientific)'s NAICS code?

Minus sign iconPlus sign icon
Intera Oncology Inc. (now a part of Boston Scientific)'s NAICS code is 3391 - Medical Equipment and Supplies Manufacturing.

How many employees does Intera Oncology Inc. (now a part of Boston Scientific) have currently?

Minus sign iconPlus sign icon
As of July 2026, Intera Oncology Inc. (now a part of Boston Scientific) has approximately 25 employees across 1 continents, including North America. Key team members include Vice President Of Marketing: J. A.Associate Director Of Quality: S. L.Clinical Education And Training Manager: T. K.. Explore Intera Oncology Inc. (now a part of Boston Scientific)'s employee directory with LeadIQ.

What industry does Intera Oncology Inc. (now a part of Boston Scientific) belong to?

Minus sign iconPlus sign icon
Intera Oncology Inc. (now a part of Boston Scientific) operates in the Medical Equipment Manufacturing industry.

What technology does Intera Oncology Inc. (now a part of Boston Scientific) use?

Minus sign iconPlus sign icon
Intera Oncology Inc. (now a part of Boston Scientific)'s tech stack includes Trident ABOneTrustElement UIWindows ServerreCAPTCHAGoogle Tag ManagerTailwind CSSCloudflare Stream.

What is Intera Oncology Inc. (now a part of Boston Scientific)'s email format?

Minus sign iconPlus sign icon
Intera Oncology Inc. (now a part of Boston Scientific)'s email format typically follows the pattern of FLast@interaoncology.com. Find more Intera Oncology Inc. (now a part of Boston Scientific) email formats with LeadIQ.

How much funding has Intera Oncology Inc. (now a part of Boston Scientific) raised to date?

Minus sign iconPlus sign icon
As of July 2026, Intera Oncology Inc. (now a part of Boston Scientific) has raised $3.7M in funding. The last funding round occurred on Aug 10, 2021 for $414K.

When was Intera Oncology Inc. (now a part of Boston Scientific) founded?

Minus sign iconPlus sign icon
Intera Oncology Inc. (now a part of Boston Scientific) was founded in 2019.
Intera Oncology Inc. (now a part of Boston Scientific) logo

Intera Oncology Inc. (now a part of Boston Scientific)

Medical Equipment ManufacturingMassachusetts, United States11-50 Employees

Intera Oncology is a medical device company based in Wellesley, Massachusetts, focused on cancer therapies for metastatic colorectal cancer and cholangiocarcinoma. Its leading product is the Intera 3000 Hepatic Artery Infusion Pump, an implantable device that delivers a continuous infusion of therapy directly to liver tumors, enabling patients to receive treatment outside hospital settings with minimal disruption to daily life. The firm sits in the medical equipment manufacturing sector and seeks to broaden access to liver-directed therapy for eligible patients, while pursuing additional solutions for other diseases with significant unmet needs. The team emphasizes expanding access to its treatment and advancing new approaches in areas with high clinical need.

In late 2024, Intera Oncology was acquired by Boston Scientific, integrating its technology within a larger medical device company. The organization is described as small to mid-sized, reflecting a focused operation within the Boston region.

Section iconCompany Overview

NAICS Code
3391 - Medical Equipment and Supplies Manufacturing
Founded
2019
Employees
11-50

Section iconFunding & Financials

  • $3.7M

    Intera Oncology Inc. (now a part of Boston Scientific) has raised a total of $3.7M of funding over 3 rounds. Their latest funding round was raised on Aug 10, 2021 in the amount of $414Kas a seed.

  • $1M$10M

    Intera Oncology Inc. (now a part of Boston Scientific)'s revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $3.7M

    Intera Oncology Inc. (now a part of Boston Scientific) has raised a total of $3.7M of funding over 3 rounds. Their latest funding round was raised on Aug 10, 2021 in the amount of $414Kas a seed.

  • $1M$10M

    Intera Oncology Inc. (now a part of Boston Scientific)'s revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.